Elyxium Wealth LLC bought a new position in shares of Philip Morris International Inc. (NYSE:PM - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,885 shares of the company's stock, valued at approximately $617,000.
Other large investors also recently made changes to their positions in the company. GQG Partners LLC grew its position in shares of Philip Morris International by 14.3% during the 4th quarter. GQG Partners LLC now owns 48,746,809 shares of the company's stock worth $5,866,678,000 after purchasing an additional 6,092,558 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Philip Morris International by 19,986.5% in the first quarter. GAMMA Investing LLC now owns 4,486,928 shares of the company's stock valued at $712,210,000 after buying an additional 4,464,590 shares in the last quarter. Kovitz Investment Group Partners LLC boosted its stake in shares of Philip Morris International by 372.2% in the fourth quarter. Kovitz Investment Group Partners LLC now owns 5,453,285 shares of the company's stock valued at $656,303,000 after buying an additional 4,298,530 shares during the period. Capital World Investors boosted its stake in shares of Philip Morris International by 3.6% in the fourth quarter. Capital World Investors now owns 122,584,210 shares of the company's stock valued at $14,752,926,000 after buying an additional 4,216,586 shares during the period. Finally, Geode Capital Management LLC grew its position in Philip Morris International by 9.9% during the fourth quarter. Geode Capital Management LLC now owns 35,286,582 shares of the company's stock worth $4,241,837,000 after buying an additional 3,185,258 shares in the last quarter. Institutional investors own 78.63% of the company's stock.
Philip Morris International Stock Performance
Shares of NYSE:PM traded down $0.42 during mid-day trading on Friday, reaching $178.75. 4,649,814 shares of the company's stock were exchanged, compared to its average volume of 5,666,761. Philip Morris International Inc. has a twelve month low of $106.76 and a twelve month high of $186.69. The firm has a market capitalization of $278.23 billion, a price-to-earnings ratio of 36.86, a PEG ratio of 2.56 and a beta of 0.51. The business's fifty day moving average price is $178.83 and its 200-day moving average price is $158.83.
Philip Morris International (NYSE:PM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $1.69 EPS for the quarter, topping analysts' consensus estimates of $1.61 by $0.08. The company had revenue of $9.30 billion for the quarter, compared to analyst estimates of $9.10 billion. Philip Morris International had a negative return on equity of 122.40% and a net margin of 8.43%. The firm's quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.50 earnings per share. Analysts predict that Philip Morris International Inc. will post 7.14 EPS for the current fiscal year.
Philip Morris International Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Friday, June 27th were issued a $1.35 dividend. The ex-dividend date of this dividend was Friday, June 27th. This represents a $5.40 dividend on an annualized basis and a yield of 3.02%. Philip Morris International's payout ratio is currently 111.34%.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the stock. Needham & Company LLC initiated coverage on shares of Philip Morris International in a research report on Thursday, May 22nd. They set a "buy" rating on the stock. Citigroup lifted their price target on Philip Morris International from $188.00 to $200.00 and gave the company a "buy" rating in a research note on Thursday, July 10th. Bank of America boosted their price target on Philip Morris International from $182.00 to $200.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Barclays raised their price objective on Philip Morris International from $220.00 to $225.00 and gave the company an "overweight" rating in a research note on Thursday, July 10th. Finally, JPMorgan Chase & Co. boosted their target price on Philip Morris International from $175.00 to $190.00 and gave the stock an "overweight" rating in a research note on Thursday, July 10th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $186.73.
Check Out Our Latest Stock Analysis on PM
Philip Morris International Company Profile
(
Free Report)
Philip Morris International Inc operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.
Featured Articles

Before you consider Philip Morris International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Philip Morris International wasn't on the list.
While Philip Morris International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.